Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Norbiato, , Marina,
DOB: 30-AUG-1999 (Age: 26)
Gender: female
Address:
Via Squarcione, 2 Piano 6
25080 Remedello Di Sotto (Italy)
ID: 5004-598122-7 (ECI)
Report
Date: 15-MAR-2022
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Ospedale di Leno
Piazzetta Donatori di sangue 1
25024 Leno (Italy)
Specimen
Collected: 15-MAR-2022

Chemistry

Test 15-MAR-2022 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.0 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 90.1 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 19.2 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.8 0.6 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 8.6 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 137.7 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.2 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 107.7 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 29.0 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All parameters are within normal limits except for a mildly elevated HbA1c (6.0%), indicating possible prediabetes or impaired glucose tolerance. Recommend clinical correlation and consideration of lifestyle modification or further evaluation for glycemic control. No evidence of renal or electrolyte disturbances.